Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-04-14 (inkl.com)
Stock Market Today: Dow Jones Up As Fed's Waller Says This On Rate Cuts; Trump Wants To 'Help' Autos But Tesla Lags (Live Coverage)
The Dow Jones rose on the stock market today and auto stocks popped after President Donald Trump spoke out. Palantir stock was higher while Nvidia…
Read more
2025-02-22 (defenseworld.net)
JPMorgan Chase & Co. Has Lowered Expectations for Charles River Laboratories International (NYSE:CRL) Stock Price -
Read JPMorgan Chase & Co. Has Lowered Expectations for Charles River Laboratories International (NYSE:CRL) Stock Price at Defense World
Read more
2025-02-22 (defenseworld.net)
Robert W. Baird Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $173.00 -
Read Robert W. Baird Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $173.00 at Defense World
Read more
2025-02-18 (defenseworld.net)
V Square Quantitative Management LLC Purchases 121 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -
Read V Square Quantitative Management LLC Purchases 121 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World
Read more
2025-02-12 (defenseworld.net)
Mirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -
Read Mirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World
Read more
2025-02-07 (defenseworld.net)
Morgan Stanley Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $184.00 -
Read Morgan Stanley Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $184.00 at Defense World
Read more
2025-02-06 (marketbeat.com)
E. Ohman J or Asset Management AB Has $480,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
E. Ohman J or Asset Management AB grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 225.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,600 shares of th
Read more
2025-01-24 (marketbeat.com)
Veracity Capital LLC Acquires New Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Veracity Capital LLC purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,191 shares of the medical research company'
Read more
2025-01-23 (investing.com)
William Blair downgrades Charles River Labs stock to Market Performance Provided by Investing.com
William Blair analysts downgraded shares of Charles River Laboratories International Inc. (NYSE: CRL) from "outperform" to "market perform" on Wednesday. The decision comes amid growing concerns about the company's near-term prospects, with the stock currently trading near its 52-week low of $160.84.
Read more
2025-01-22 (investing.com)
TD Cowen Cuts Charles River Labs Price Target Amid Revenue Pressures By Investing.com
TD Cowen Cuts Charles River Labs Price Target Due to Earnings Pressure
Read more
2025-01-22 (investing.com)
William Blair Downgrades Charles River Labs Shares to Perform From Investing.com
William Blair Downgrades Charles River Labs Shares to Market Perform
Read more
2025-01-22 (investing.com)
TD Cowen cuts Charles River Labs stock price target amid revenue pressures From Investing.com
TD Cowen cuts Charles River Labs stock price target amid revenue pressures
Read more